Relay Therapeutics (RLAY) Change in Acquisitions & Divestments (2020 - 2025)
Relay Therapeutics (RLAY) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with $69.5 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments fell 33.26% to $69.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $316.2 million through Dec 2025, down 48.3% year-over-year, with the annual reading at $316.2 million for FY2025, 48.3% down from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was $69.5 million at Relay Therapeutics, down from $97.8 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $386.2 million in Q1 2021, with the low at $18.1 million in Q1 2022.
- Average Change in Acquisitions & Divestments over 5 years is $123.0 million, with a median of $100.9 million recorded in 2024.
- The sharpest move saw Change in Acquisitions & Divestments crashed 95.31% in 2022, then skyrocketed 867.09% in 2023.
- Over 5 years, Change in Acquisitions & Divestments stood at $35.2 million in 2021, then surged by 419.21% to $183.0 million in 2022, then increased by 7.43% to $196.6 million in 2023, then crashed by 47.07% to $104.1 million in 2024, then plummeted by 33.26% to $69.5 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $69.5 million, $97.8 million, and $84.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.